Akari Therapeutics (AKTX) Cash & Current Investments (2011 - 2026)
Akari Therapeutics recorded quarterly Cash & Current Investments of $2.8 million in Q1 2026, down 46.8% quarter-over-quarter from $5.2 million in Q4 2025, and up 4.77% year-over-year from $2.6 million in Q1 2025.
Akari Therapeutics' Cash & Current Investments history runs 16 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 4.77% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (up 4.77% YoY), while the FY2025 annual figure was $5.2 million, up 95.68% from the prior year.
- Cash & Current Investments came in at $2.8 million for Q1 2026 at Akari Therapeutics, down from $5.2 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $13.2 million in Q4 2022 to a low of $162567.0 in Q3 2025.
- A 5-year average of $4.8 million and a median of $3.3 million in 2023 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments slumped 99.91% in 2022 and soared 101.68% in 2025, its largest moves.
- Akari Therapeutics' Cash & Current Investments stood at $13.2 million in 2022, then slumped by 70.98% to $3.8 million in 2023, then sank by 30.85% to $2.7 million in 2024, then surged by 95.68% to $5.2 million in 2025, then plunged by 46.8% to $2.8 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $2.8 million, $5.2 million, and $162567.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.13 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.01 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.77 Mn |
| Dec 31, 2025 | 5.20 Mn |
| Sep 30, 2025 | 162,567.00 |
| Jun 30, 2025 | 2.71 Mn |
| Mar 31, 2025 | 2.58 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Sep 30, 2024 | 2.25 Mn |
| Jun 30, 2024 | 4.18 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 3.85 Mn |
| Jun 30, 2023 | 13.25 Mn |
| Dec 31, 2022 | 13.25 Mn |
| Jun 30, 2022 | 8.15 Mn |
| Mar 31, 2022 | 16.72 Mn |
| Dec 31, 2021 | 9,319.00 |
| Sep 30, 2021 | 13.39 Mn |
| Jun 30, 2021 | 14.06 Mn |
| Mar 31, 2021 | 6.67 Mn |
| Dec 31, 2020 | 5.72 Bn |
| Sep 30, 2020 | 12.32 Mn |
| Jun 30, 2020 | 12.75 Mn |
| Mar 31, 2020 | 7.82 Mn |
| Dec 31, 2019 | 5.72 Mn |
| Sep 30, 2019 | 5.97 Mn |
| Jun 30, 2019 | 2.75 Mn |
| Mar 31, 2019 | 6.12 Mn |
| Dec 31, 2018 | 6.44 Mn |
| Sep 30, 2018 | 10.59 Mn |
| Jun 30, 2018 | 15.59 Mn |
| Mar 31, 2018 | 23.92 Mn |
| Dec 31, 2017 | 28.25 Mn |
| Sep 30, 2017 | 21.12 Mn |
| Jun 30, 2017 | 34.10 Mn |
| Mar 31, 2017 | 44.12 Mn |
| Dec 31, 2016 | 44.14 Mn |
| Sep 30, 2016 | 114.02 Mn |
| Jun 30, 2016 | 115.04 Mn |
| Mar 31, 2016 | 61.43 Mn |
| Dec 31, 2015 | 68.92 Mn |
| Sep 30, 2015 | 3.33 Mn |
| Jun 30, 2015 | 3.33 Mn |
| Mar 31, 2015 | 1.33 Mn |
| Dec 31, 2014 | 3.33 Mn |
| Sep 30, 2014 | 52,614.00 |
| Jun 30, 2014 | 11.36 Mn |
| Mar 31, 2014 | 13.83 Mn |
| Dec 31, 2013 | 553,654.00 |
| Dec 31, 2012 | 1.10 Mn |
| Dec 31, 2011 | 6,000.00 |